These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 21784892)
1. Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy. Cravedi P; Ruggenenti P; Remuzzi G J Am Soc Nephrol; 2011 Aug; 22(8):1400-2. PubMed ID: 21784892 [No Abstract] [Full Text] [Related]
2. [Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?]. Netti GS; Ranieri E G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030016 [TBL] [Abstract][Full Text] [Related]
3. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. Debiec H; Ronco P N Engl J Med; 2011 Feb; 364(7):689-90. PubMed ID: 21323563 [No Abstract] [Full Text] [Related]
4. [Preliminary results of research on a new marker of idiopathic membranous nephropathy: anti-PLA2R]. Kozioł M; Sikora A; Kozioł-Montewka M; Smarz-Widelska I; Orłowska-Kowalik G; Pyszna W; Załuska W; Ksiazek A Pol Merkur Lekarski; 2014 Mar; 36(213):171-4. PubMed ID: 24779214 [TBL] [Abstract][Full Text] [Related]
5. Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab. van de Logt AE; Dahan K; Rousseau A; van der Molen R; Debiec H; Ronco P; Wetzels J Kidney Int; 2018 Apr; 93(4):1016-1017. PubMed ID: 29571438 [No Abstract] [Full Text] [Related]
6. PLA2R autoantibodies and recurrent membranous nephropathy after transplantation. Stahl R; Hoxha E; Fechner K N Engl J Med; 2010 Jul; 363(5):496-8. PubMed ID: 20818871 [No Abstract] [Full Text] [Related]
8. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981 [TBL] [Abstract][Full Text] [Related]
10. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555 [TBL] [Abstract][Full Text] [Related]
11. Circulating antibodies to α-enolase and phospholipase A Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547 [TBL] [Abstract][Full Text] [Related]
12. [Membranous glomerulonephritis: better therapy with autoantibody monitoring?]. Stahl RA; Hoxha E; Helmchen U Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1733-7. PubMed ID: 21877306 [TBL] [Abstract][Full Text] [Related]
13. Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study. Provatopoulou S; Kalavrizioti D; Stangou M; Kouri MN; Kalliakmani P; Papasotiriou M; Papachristou E; Goumenos DS; Papagianni A Rom J Intern Med; 2019 Jun; 57(2):141-150. PubMed ID: 30864406 [TBL] [Abstract][Full Text] [Related]
14. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223 [TBL] [Abstract][Full Text] [Related]
15. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy. Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075 [TBL] [Abstract][Full Text] [Related]
16. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy. Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198 [TBL] [Abstract][Full Text] [Related]
17. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kanigicherla D; Gummadova J; McKenzie EA; Roberts SA; Harris S; Nikam M; Poulton K; McWilliam L; Short CD; Venning M; Brenchley PE Kidney Int; 2013 May; 83(5):940-8. PubMed ID: 23364522 [TBL] [Abstract][Full Text] [Related]
18. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. Beck LH; Fervenza FC; Beck DM; Bonegio RG; Malik FA; Erickson SB; Cosio FG; Cattran DC; Salant DJ J Am Soc Nephrol; 2011 Aug; 22(8):1543-50. PubMed ID: 21784898 [TBL] [Abstract][Full Text] [Related]
19. Anti-PLA2R antibody in a secondary cause of membranous nephropathy. Hari Krishna Reddy M; Kumar AC; Sangeetha B; Ram R; Siva Kumar V Nephrology (Carlton); 2018 Jan; 23(1):94-95. PubMed ID: 29250915 [No Abstract] [Full Text] [Related]
20. Accelerating the Depletion of Circulating Anti-Phospholipase A2 Receptor Antibodies in Patients with Severe Membranous Nephropathy: Preliminary Findings with Double Filtration Plasmapheresis and Ofatumumab. Podestà MA; Gennarini A; Portalupi V; Rota S; Alessio MG; Remuzzi G; Ruggenenti P Nephron; 2020; 144(1):30-35. PubMed ID: 31336376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]